| Item Type | Name |
|
Concept
|
Viral Core Proteins
|
|
Concept
|
Cytoskeletal Proteins
|
|
Concept
|
Proto-Oncogene Proteins c-myc
|
|
Concept
|
Recombinant Fusion Proteins
|
|
Concept
|
Viral Nonstructural Proteins
|
|
Concept
|
Mitochondrial Proteins
|
|
Concept
|
Fanconi Anemia Complementation Group Proteins
|
|
Concept
|
Nuclear Proteins
|
|
Concept
|
Recombinant Proteins
|
|
Concept
|
Iron-Binding Proteins
|
|
Concept
|
Viral Proteins
|
|
Concept
|
Proteins
|
|
Concept
|
Serotonin Plasma Membrane Transport Proteins
|
|
Concept
|
Membrane Proteins
|
|
Concept
|
Insulin Receptor Substrate Proteins
|
|
Concept
|
Fatty Acid-Binding Proteins
|
|
Concept
|
Contractile Proteins
|
|
Concept
|
Neoplasm Proteins
|
|
Concept
|
Microfilament Proteins
|
|
Concept
|
Cation Transport Proteins
|
|
Concept
|
Blood Proteins
|
|
Academic Article
|
Cloning, sequencing and expression of cDNA for chick liver haem oxygenase. Comparison of avian and mammalian cDNAs and deduced proteins.
|
|
Academic Article
|
A detailed analysis of the Knodell score and other histologic parameters as predictors of response to interferon therapy in chronic hepatitis C.
|
|
Academic Article
|
High-dose interferon-alpha 2b for re-treatment of nonresponders or relapsing patients with chronic hepatitis C. A controlled randomized trial.
|
|
Academic Article
|
Effect of interferon therapy on bile duct inflammation in hepatitis C.
|
|
Academic Article
|
Regulation of expression of the human heme oxygenase-1 gene in transfected chick embryo liver cell cultures.
|
|
Academic Article
|
Mechanism of sodium arsenite-mediated induction of heme oxygenase-1 in hepatoma cells. Role of mitogen-activated protein kinases.
|
|
Academic Article
|
Porphyria cutanea tarda, hepatitis C, and HFE gene mutations in North America.
|
|
Academic Article
|
Interleukin-8 and hIRH (SDF1-alpha/PBSF) mRNA expression and histological activity index in patients with chronic hepatitis C.
|
|
Academic Article
|
Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy. The Consensus Interferon Study Group.
|
|
Academic Article
|
Hepatic iron concentration: noninvasive estimation by means of MR imaging techniques.
|
|
Academic Article
|
Non-alcoholic steatohepatitis and iron: increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis.
|
|
Academic Article
|
IFN-alpha receptor mRNA expression in a United States sample with predominantly genotype 1a/I chronic hepatitis C liver biopsies correlates with response to IFN therapy.
|
|
Academic Article
|
Heme oxygenase: recent advances in understanding its regulation and role.
|
|
Academic Article
|
Effects of antidepressants and benzodiazepine-type anxiolytic agents on hepatic porphyrin accumulation in primary cultures of chick embryo liver cells.
|
|
Academic Article
|
Effects of phenylarsine oxide on expression of heme oxygenase-1 reporter constructs in transiently transfected cultures of chick embryo liver cells.
|
|
Academic Article
|
Upstream regulatory elements in chick heme oxygenase-1 promoter: a study in primary cultures of chick embryo liver cells.
|
|
Academic Article
|
Role of HFE gene mutations in liver diseases other than hereditary hemochromatosis.
|
|
Academic Article
|
Ubiquitin as a marker of cell injury in nonalcoholic steatohepatitis.
|
|
Academic Article
|
Urea and hypertonicity increase expression of heme oxygenase-1 in murine renal medullary cells.
|
|
Academic Article
|
Comparative effects of different doses of ribavirin plus interferon-alpha2b for therapy of chronic hepatitis C: results of a controlled, randomized trial.
|
|
Academic Article
|
Intestinal expression of genes involved in iron absorption in humans.
|
|
Academic Article
|
Iron and HFE or TfR1 mutations as comorbid factors for development and progression of chronic hepatitis C.
|
|
Academic Article
|
Vascular endothelial growth factor increases heme oxygenase-1 protein expression in the chick embryo chorioallantoic membrane.
|
|
Academic Article
|
Iron as a co-morbid factor in nonhemochromatotic liver disease.
|
|
Academic Article
|
Peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatment.
|
|
Academic Article
|
Identification of key elements that are responsible for heme-mediated induction of the avian heme oxygenase-1 gene.
|
|
Academic Article
|
Evolution of the HALT-C Trial: pegylated interferon as maintenance therapy for chronic hepatitis C in previous interferon nonresponders.
|
|
Academic Article
|
Role of Bach-1 in regulation of heme oxygenase-1 in human liver cells: insights from studies with small interfering RNAS.
|
|
Academic Article
|
Hemochromatosis mutations in Iranians with hepatitis B virus infection.
|
|
Academic Article
|
Evolution of the intrahepatic T cell repertoire during chronic hepatitis C virus infection.
|
|
Academic Article
|
No role of the -2518 promoter polymorphism of monocyte chemotactic protein-1 in chronic hepatitis C.
|
|
Academic Article
|
Hepatitis C virus-specific immune responses and quasi-species variability at baseline are associated with nonresponse to antiviral therapy during advanced hepatitis C.
|
|
Academic Article
|
HCV proteins increase expression of heme oxygenase-1 (HO-1) and decrease expression of Bach1 in human hepatoma cells.
|
|
Academic Article
|
HCV RNA detection by TMA during the hepatitis C antiviral long-term treatment against cirrhosis (Halt-C) trial.
|
|
Academic Article
|
Role of Bach1 and Nrf2 in up-regulation of the heme oxygenase-1 gene by cobalt protoporphyrin.
|
|
Academic Article
|
Roles of iron and HFE mutations on severity and response to therapy during retreatment of advanced chronic hepatitis C.
|
|
Academic Article
|
Impact of disease severity on outcome of antiviral therapy for chronic hepatitis C: Lessons from the HALT-C trial.
|
|
Academic Article
|
Health-related quality of life in patients with chronic hepatitis C and advanced fibrosis.
|
|
Academic Article
|
Impact of reducing peginterferon alfa-2a and ribavirin dose during retreatment in patients with chronic hepatitis C.
|
|
Academic Article
|
Hepatic steatosis in hepatitis C: comparison of diabetic and nondiabetic patients in the hepatitis C antiviral long-term treatment against cirrhosis trial.
|
|
Academic Article
|
Antiviral response of HCV genotype 1 to consensus interferon and ribavirin versus pegylated interferon and ribavirin.
|
|
Academic Article
|
Reciprocal effects of micro-RNA-122 on expression of heme oxygenase-1 and hepatitis C virus genes in human hepatocytes.
|
|
Academic Article
|
Herbal product use by persons enrolled in the hepatitis C Antiviral Long-Term Treatment Against Cirrhosis (HALT-C) Trial.
|
|
Academic Article
|
Blunted cytopenias and weight loss: new correlates of virologic null response to re-treatment of chronic hepatitis C.
|
|
Academic Article
|
Vascular endothelium as a contributor of plasma sphingosine 1-phosphate.
|
|
Academic Article
|
Zinc mesoporphyrin induces rapid and marked degradation of the transcription factor Bach1 and up-regulates HO-1.
|
|
Academic Article
|
DNA polymorphisms and response to treatment in patients with chronic hepatitis C: results from the HALT-C trial.
|
|
Academic Article
|
Efficacy and safety of peginterferon alfa-2a/ribavirin in methadone maintenance patients: randomized comparison of direct observed therapy and self-administration.
|
|
Academic Article
|
Hereditary hemochromatosis: time for targeted screening.
|
|
Academic Article
|
Differential regulation of human ALAS1 mRNA and protein levels by heme and cobalt protoporphyrin.
|
|
Academic Article
|
Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease.
|
|
Academic Article
|
Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferon.
|
|
Academic Article
|
Serum fibrosis marker levels decrease after successful antiviral treatment in chronic hepatitis C patients with advanced fibrosis.
|
|
Academic Article
|
Evolution of hepatic steatosis in patients with advanced hepatitis C: results from the hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) trial.
|
|
Academic Article
|
Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trial.
|
|
Academic Article
|
Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis C.
|
|
Academic Article
|
Effect of HCV RNA suppression during peginterferon alfa-2a maintenance therapy on clinical outcomes in the HALT-C trial.
|
|
Academic Article
|
Iron increases HMOX1 and decreases hepatitis C viral expression in HCV-expressing cells.
|
|
Academic Article
|
Merimepodib, pegylated interferon, and ribavirin in genotype 1 chronic hepatitis C pegylated interferon and ribavirin nonresponders.
|
|
Academic Article
|
Zinc mesoporphyrin induces rapid proteasomal degradation of hepatitis C nonstructural 5A protein in human hepatoma cells.
|
|
Academic Article
|
Changes in quality of life and sexual health are associated with low-dose peginterferon therapy and disease progression in patients with chronic hepatitis C.
|
|
Academic Article
|
MicroRNA-196 represses Bach1 protein and hepatitis C virus gene expression in human hepatoma cells expressing hepatitis C viral proteins.
|
|
Academic Article
|
A functional serotonin transporter gene polymorphism and depressive effects associated with interferon-alpha treatment.
|
|
Academic Article
|
Outcome of sustained virological responders with histologically advanced chronic hepatitis C.
|
|
Academic Article
|
Serum fibrosis markers are associated with liver disease progression in non-responder patients with chronic hepatitis C.
|
|
Academic Article
|
Maintenance peginterferon therapy and other factors associated with hepatocellular carcinoma in patients with advanced hepatitis C.
|
|
Academic Article
|
Development and progression of portal hypertensive gastropathy in patients with chronic hepatitis C.
|
|
Academic Article
|
Iron levels in hepatocytes and portal tract cells predict progression and outcomes of patients with advanced chronic hepatitis C.
|
|
Academic Article
|
Structural analysis of heme proteins: implications for design and prediction.
|
|
Academic Article
|
Excess mortality in patients with advanced chronic hepatitis C treated with long-term peginterferon.
|
|
Academic Article
|
Legalon-SIL downregulates HCV core and NS5A in human hepatocytes expressing full-length HCV.
|
|
Academic Article
|
A prospective study of the rate of progression in compensated, histologically advanced chronic hepatitis C.
|
|
Academic Article
|
Lon peptidase 1 (LONP1)-dependent breakdown of mitochondrial 5-aminolevulinic acid synthase protein by heme in human liver cells.
|
|
Academic Article
|
Association of filamin A and vimentin with hepatitis C virus proteins in infected human hepatocytes.
|
|
Academic Article
|
YKL-40 genetic polymorphisms and the risk of liver disease progression in patients with advanced fibrosis due to chronic hepatitis C.
|
|
Academic Article
|
Serum proteomic profiling in patients with drug-induced liver injury.
|
|
Academic Article
|
Antigen-specific T lymphocyte proliferation decreases over time in advanced chronic hepatitis C.
|
|
Academic Article
|
The let-7 microRNA enhances heme oxygenase-1 by suppressing Bach1 and attenuates oxidant injury in human hepatocytes.
|
|
Academic Article
|
Identification of differentially expressed proteins from primary versus metastatic pancreatic cancer cells using subcellular proteomics.
|
|
Academic Article
|
Cytoskeletal proteins: shaping progression of hepatitis C virus-induced liver disease.
|
|
Academic Article
|
Intravenous interferon administered during liver transplantation is not effective in preventing hepatitis C reinfection.
|
|
Academic Article
|
Differences in glycogen, lipids, and enzymes in livers from rats flown on COSMOS 2044.
|
|
Academic Article
|
Recent insights into the biological functions of liver fatty acid binding protein 1.
|
|
Academic Article
|
Genetic factors that affect nonalcoholic fatty liver disease: A systematic clinical review.
|
|
Academic Article
|
BMP4 promotes metastasis of hepatocellular carcinoma by an induction of epithelial-mesenchymal transition via upregulating ID2.
|
|
Academic Article
|
miR-122 inhibition in a human liver organoid model leads to liver inflammation, necrosis, steatofibrosis and dysregulated insulin signaling.
|
|
Academic Article
|
Strong correlation of ferrochelatase enzymatic activity with Mitoferrin-1 mRNA in lymphoblasts of patients with protoporphyria.
|